XCMR Principal Scientist Ernest R. Blatchley III Presents at 2021 EPA International Decontamination Conference

Ernest R. Blatchley III, XCMR’s Principal Scientist, presented groundbreaking research on Far UV-C technology at the 2021 EPA International Decontamination Conference.

The presentation highlighted XCMR’s innovative Far UV-C microplasma lamps, which offer real-time airborne pathogen inactivation for enhanced public health protection.

Summary

Ernest R. Blatchley III, Principal Scientist of Process Engineering at XCMR, presented XCMR’s cutting-edge research on Far UV-C technology at the 2021 EPA International Decontamination Research & Development Conference. Hosted by the U.S. Environmental Protection Agency (EPA), the conference brought together leaders in government, industry, and academia to discuss innovations in decontamination research, with the goal of improving public health and safety in response to biological and environmental threats. Abstracts from the conference presentation are available here.

Presentation Highlights

1. Far UV-C Technology for Real-Time Pathogen Inactivation

Presenter: Ernest R. Blatchley III, Principal Scientist, Process Engineering, XCMR

Blatchley’s presentation centered on XCMR’s groundbreaking Near-field Infection Protection (NIP™) technology, which utilizes Far UV-C radiation at 222 nm to continuously inactivate airborne pathogens and microbes on surfaces. Unlike conventional UV-C systems, Far UV-C radiation does not pose a risk to human health, as it cannot penetrate the skin or eyes. XCMR’s NIP devices are designed for personal workspace protection and can be used in a variety of settings, including offices, healthcare environments, and schools. This technology has the potential to significantly reduce reliance on single-use PPE and lower the incidence of respiratory diseases.

2. Aligning with EPA’s Decontamination Goals

The EPA’s Decontamination Research Program supports the development of technologies that protect public health from hazardous materials, including biological agents. XCMR’s Near-field Infection Protection™ technology aligns with these objectives by providing a sustainable, effective method for continuous disinfection in personal environments, ensuring protection during interpersonal interactions and daily activities.

3. Recognition Leading to Phase 1 SBIR Award

XCMR received a $99,771 Phase 1 SBIR award from the EPA to further support the development of its Far UV-C technology. This award recognizes the potential of XCMR’s Far UV-C technology to revolutionize infection control and decontamination methods, providing real-time pathogen inactivation for a wide range of environments.

Conclusion

XCMR’s participation in the 2021 EPA International Decontamination Conference, led by Ernest R. Blatchley III, underscores the company’s commitment to advancing Far UV-C technology for public health. With the development of Near-field Infection Protection devices, XCMR is at the forefront of creating innovative, human-safe solutions that can continuously protect against airborne pathogens and reduce the need for traditional PPE.

Let's Partner.